EXE vs. ZVRA
EXE (Expand Energy Corp) and ZVRA (Zevra Therapeutics Inc.) are both stocks. EXE operates in Oil & Gas E&P (Energy), while ZVRA operates in Biotechnology (Healthcare). Over the past 5 years, EXE returned 14.81%/yr vs -2.85%/yr for ZVRA. At a 0.14 correlation, their price movements are largely independent.
Performance
EXE vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EXE achieves a -18.63% return, which is significantly lower than ZVRA's 41.18% return.
EXE
- 1D
- 1.95%
- 1M
- -6.62%
- YTD
- -18.63%
- 6M
- -20.38%
- 1Y
- -20.29%
- 3Y*
- 6.27%
- 5Y*
- 14.81%
- 10Y*
- —
ZVRA
- 1D
- -2.47%
- 1M
- 13.76%
- YTD
- 41.18%
- 6M
- 51.86%
- 1Y
- 35.01%
- 3Y*
- 29.54%
- 5Y*
- -2.85%
- 10Y*
- -16.40%
EXE vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
EXE Expand Energy Corp | -18.63% | 14.35% | 33.18% | -14.77% | 62.34% | 53.16% |
ZVRA Zevra Therapeutics Inc. | 41.18% | 7.43% | 27.33% | 42.70% | -47.30% | -4.29% |
Correlation
The correlation between EXE and ZVRA is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Feb 10, 2021 | 0.14 |
The correlation between EXE and ZVRA shifts across timeframes, from 0.00 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.
Fundamentals
EXE:
$21.37M
ZVRA:
$761.92M
EXE:
$17.89
ZVRA:
$2.16
EXE:
4.96
ZVRA:
5.85
EXE:
1.14
ZVRA:
5.94
EXE:
0.00
ZVRA:
3.70
EXE:
$14.10B
ZVRA:
$122.29M
EXE:
$8.89B
ZVRA:
$104.94M
EXE:
$7.00B
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EXE vs. ZVRA — Risk / Return Rank
EXE
ZVRA
EXE vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Expand Energy Corp (EXE) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EXE | ZVRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.20 | ||
| Sortino ratioReturn per unit of downside risk | -2.04 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.16 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.72 | 0.81 | -1.53 |
| Martin ratioReturn relative to average drawdown | -1.31 | 1.41 | -2.72 |
Loading charts...
Drawdowns
EXE vs. ZVRA - Drawdown Comparison
The maximum EXE drawdown since its inception was -29.69%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for EXE and ZVRA.
Loading charts...
Drawdown Indicators
| EXE | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -29.69% | -99.27% | +69.58% |
Max Drawdown (1Y)Largest decline over 1 year | -28.32% | -43.47% | +15.15% |
Max Drawdown (3Y)Largest decline over 3 years | -28.32% | -43.47% | +15.15% |
Max Drawdown (5Y)Largest decline over 5 years | -29.69% | -74.01% | +44.32% |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.85% | — |
Current DrawdownCurrent decline from peak | -26.92% | -96.65% | +69.73% |
Average DrawdownAverage peak-to-trough decline | -10.98% | -86.41% | +75.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.50% | 24.87% | -9.37% |
Volatility
EXE vs. ZVRA - Volatility Comparison
The current volatility for Expand Energy Corp (EXE) is 7.74%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 24.56%. This indicates that EXE experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EXE | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.74% | 24.56% | -16.82% |
Volatility (6M)Calculated over the trailing 6-month period | 22.57% | 40.23% | -17.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.76% | 62.90% | -31.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.13% | 60.49% | -25.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.78% | 81.46% | -46.68% |
Dividends
EXE vs. ZVRA - Dividend Comparison
EXE's dividend yield for the trailing twelve months is around 3.59%, while ZVRA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
EXE Expand Energy Corp | 3.59% | 2.89% | 2.45% | 4.70% | 10.16% | 1.74% |
ZVRA Zevra Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
EXE vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between Expand Energy Corp and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EXE and ZVRA have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (24.56%) compared to EXE (7.74%). In terms of maximum drawdown, EXE dropped -29.69% vs ZVRA's -99.27%.
ZVRA currently has the higher Sharpe Ratio (0.56 vs -0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EXE and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer